TESCALA

Table of contents:

Trademark domain
nameis free?
tescala.com

The "TESCALA" trademark, serial number 78128319 , was filed on 13th of May 2002 with a mark drawing code of 1000 and its transaction date is 78128319. The attorney assigned is Christopher N. Bolinger and Arthur Silverstein, Richard Friedman, Cynthia Arellano, Tiffany Trunko, Jennet Walker, Sudipta Rao, Stacey Hallerman, Cindy M. Zelson, Heather McDonald, Jane Ungaro, Warren Zeserman, Romy Corliss and Judy McCool., attorney docket number PHR/USA/TESC. Since 31st of December 2009, the document can be found in the L20 law office in the publication and issue section. The employee responsible is CLARKE, NANCY L and the date it was published for opposition on 11/05/2002. The status of the trademark was checked last on 01/29/2006.

The corresponded responsible for this trademark is Christopher N. Bolinger, located at Pfizer Inc., 150 East 42nd Street, New York NY 10017.

The state or country where the trademark was organized is NY by Pfizer Inc.. The legal entity type behing it is a Corporation, located at 235 East 42nd Street, New York, NY zip 10017.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Status Date05/17/2002
Primary Code005
Goods codes
GS0051Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations
PROSECUTION HISTORY
DateDescriptionTypeCode
06/16/2005 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
05/01/2003 EXTENSION 1 FILED S EXT1 - EXTENSION 1 FILED
04/04/2006 ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED O - Outgoing Correspondence MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
04/04/2006 ABANDONMENT - NO USE STATEMENT FILED S ABN6 - ABANDONMENT - NO USE STATEMENT FILED
06/16/2005 EXTENSION 5 GRANTED S EX5G - EXTENSION 5 GRANTED
06/16/2005 EXTENSION 5 FILED S EXT5 - EXTENSION 5 FILED
01/21/2005 EXTENSION 4 GRANTED S EX4G - EXTENSION 4 GRANTED
01/05/2005 EXTENSION 4 FILED S EXT4 - EXTENSION 4 FILED
01/05/2005 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
01/05/2005 ATTORNEY REVOKED AND/OR APPOINTED I - Incoming Correspondence ARAA - ATTORNEY REVOKED AND/OR APPOINTED
01/05/2005 TEAS REVOKE/APPOINT ATTORNEY RECEIVED I - Incoming Correspondence REAP - TEAS REVOKE/APPOINT ATTORNEY RECEIVED
04/22/2004 EXTENSION 3 GRANTED S EX3G - EXTENSION 3 GRANTED
04/07/2004 EXTENSION 3 FILED S EXT3 - EXTENSION 3 FILED
04/15/2004 CASE FILE IN TICRS O - Outgoing Correspondence CFIT - CASE FILE IN TICRS
04/07/2004 PAPER RECEIVED I - Incoming Correspondence MAIL - PAPER RECEIVED
11/21/2003 EXTENSION 2 GRANTED S EX2G - EXTENSION 2 GRANTED
11/21/2003 EXTENSION 2 FILED S EXT2 - EXTENSION 2 FILED
11/26/2003 PAPER RECEIVED I - Incoming Correspondence MAIL - PAPER RECEIVED
06/04/2003 EXTENSION 1 GRANTED S EX1G - EXTENSION 1 GRANTED
05/01/2003 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
01/28/2003 NOA MAILED - SOU REQUIRED FROM APPLICANT O - Outgoing Correspondence NOAM - NOTICE OF ALLOWANCE-MAILED
11/05/2002 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
10/16/2002 NOTICE OF PUBLICATION O - Outgoing Correspondence NPUB - NOTICE OF PUBLICATION
09/16/2002 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
09/16/2002 EXAMINER'S AMENDMENT MAILED F - First Action CNEA - EXAMINER'S AMENDMENT MAILED
08/29/2002 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER

The "TESCALA" trademark, serial number 78798927 , was filed on 25th of January 2006 with a mark drawing code of 4000 and its transaction date is 78798927. The attorney assigned is Jane Ungaro, attorney docket number TESCALA/US. Since 31st of December 2009, the document can be found in the M60 law office in the publication and issue section. The employee responsible is FRENCH, CURTIS W and the date it was published for opposition on 09/12/2006. The status of the trademark was checked last on 01/05/2009.

Other trademarks by this attorney include , GIBRALT , VICURON . The corresponded responsible for this trademark is Jane Ungaro, located at Pfizer Inc., 150/5, 235 East 42nd Street.

The state or country where the trademark was organized is NY by Pfizer Inc.. The legal entity type behing it is a Corporation, located at 235 East 42nd Street, New York, NY zip 10017.Other trademarks by this applicant: THEROSCA.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status6 - Active
Primary Code005
Status Date01/31/2006
Goods codes
GS0051Pharmaceutical preparations for the treatment of cardiovascular disease, central nervous system diseases and disorders, neurological disorders, urological, urogenital and urinary disorders, gastrointestinal disorders, musculoskeletal disorders, allergies, diabetes, hypertension, erectile dysfunction, sexual dysfunction, stroke, cancer, migraines, pain, obesity, inflammation and inflammatory diseases, respiratory and infectious diseases, and immunological, bacterial, viral and fungal disorders; pharmaceutical preparations, namely, preparations to lower cholesterol, smoking cessation preparations, tissue and skin repair preparations, dermatological preparations, and gynecological preparations
PROSECUTION HISTORY
DateDescriptionTypeCode
12/05/2006 NOA MAILED - SOU REQUIRED FROM APPLICANT O - Outgoing Correspondence NOAM - NOTICE OF ALLOWANCE-MAILED
01/05/2009 ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED O - Outgoing Correspondence MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
01/05/2009 ABANDONMENT - NO USE STATEMENT FILED S ABN6 - ABANDONMENT - NO USE STATEMENT FILED
06/02/2008 EXTENSION 3 GRANTED S EX3G - EXTENSION 3 GRANTED
05/27/2008 EXTENSION 3 FILED S EXT3 - EXTENSION 3 FILED
05/27/2008 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
12/03/2007 EXTENSION 2 GRANTED S EX2G - EXTENSION 2 GRANTED
11/14/2007 EXTENSION 2 FILED S EXT2 - EXTENSION 2 FILED
11/14/2007 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
08/25/2007 EXTENSION 1 GRANTED S EX1G - EXTENSION 1 GRANTED
06/01/2007 EXTENSION 1 FILED S EXT1 - EXTENSION 1 FILED
06/01/2007 TEAS CHANGE OF CORRESPONDENCE RECEIVED I - Incoming Correspondence TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/01/2007 TEAS EXTENSION RECEIVED I - Incoming Correspondence EEXT - TEAS EXTENSION RECEIVED
09/12/2006 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
08/23/2006 NOTICE OF PUBLICATION O - Outgoing Correspondence NPUB - NOTICE OF PUBLICATION
07/18/2006 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
07/07/2006 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
07/06/2006 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
06/19/2006 EXAMINER'S AMENDMENT MAILED F - First Action CNEA - EXAMINER'S AMENDMENT MAILED
06/19/2006 EXAMINER'S AMENDMENT ENTERED I - Incoming Correspondence XAEC - EXAMINER'S AMENDMENT ENTERED
06/19/2006 EXAMINERS AMENDMENT -WRITTEN R - Renewal CNEA - EXAMINERS AMENDMENT -WRITTEN
06/14/2006 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
01/31/2006 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM

The "TESCALA" trademark, serial number 77657635 , was filed on 27th of January 2009 with a mark drawing code of 4000 and its transaction date is 77657635. The attorney assigned is Jane Ungaro, attorney docket number . Since 31st of December 2009, the document can be found in the L30 law office in the publication and issue section. The employee responsible is HALL, ALLISON E and the date it was published for opposition on 05/05/2009. The status of this trademark was checked last on 08/20/2009.

Other trademarks by this attorney include , VICURON . The corresponded responsible for this trademark is JANE UNGARO, located at PFIZER INC., 150 EAST 42ND STREET, 150/5.

The state or country where the trademark was organized is NY by Pfizer Inc.. The legal entity type behing it is a Corporation, located at 235 East 42nd Street, New York, NY zip 10017.

GOODS AND/OR SERVICES
International Class - 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
U.S. Class052 - Detergents and Soaps
Class Status8 - Abandoned
Status Date08/20/2009
Primary Code005
Goods codes
GS0051Pharmaceutical preparations for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, gynecological, hematologic, immunological, infectious, inflammatory, menopausal, metabolic, musculoskeletal, neurological, oncological, ophthalmological, psychiatric, respiratory, sleep, urogenital, urological and viral diseases and disorders; pharmaceutical preparations for the treatment of allergies, erectile dysfunction, sexual dysfunction, obesity, pain, and HIV/AIDS; pharmaceutical preparations, namely, antifungal preparations, dermatological preparations, smoking cessation preparations; vaccines for human use; adjuvants for use with human vaccines; pharmaceutical preparations for the treatment of Alzheimer's and Huntington's diseases
PROSECUTION HISTORY
DateDescriptionTypeCode
08/20/2009 ABANDONMENT NOTICE MAILED - AFTER PUBLICATION O - Outgoing Correspondence MAB5 - ABANDONMENT NOTICE MAILED - AFTER PUBLICATION
08/20/2009 ABANDONMENT - AFTER PUBLICATION O - Outgoing Correspondence ABN5 - ABANDONMENT - AFTER PUBLICATION
08/19/2009 TEAS EXPRESS ABANDONMENT RECEIVED I - Incoming Correspondence EXAR - TEAS EXPRESS ABANDONMENT RECEIVED
07/28/2009 NOA MAILED - SOU REQUIRED FROM APPLICANT O - Outgoing Correspondence NOAM - NOTICE OF ALLOWANCE-MAILED
05/05/2009 PUBLISHED FOR OPPOSITION A - Allowance for Publication PUBO - PUBLISHED FOR OPPOSITION
04/15/2009 NOTICE OF PUBLICATION O - Outgoing Correspondence NPUB - NOTICE OF PUBLICATION
04/02/2009 LAW OFFICE PUBLICATION REVIEW COMPLETED O - Outgoing Correspondence PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
04/01/2009 ASSIGNED TO LIE A - Allowance for Publication ALIE - ASSIGNED TO LIE
04/01/2009 APPROVED FOR PUB - PRINCIPAL REGISTER P CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
03/25/2009 ASSIGNED TO EXAMINER D - Assigned to Examiner DOCK - ASSIGNED TO EXAMINER
01/30/2009 NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM I - Incoming Correspondence NWOS
01/30/2009 NEW APPLICATION ENTERED IN TRAM I - Incoming Correspondence NWAP - NEW APPLICATION ENTERED IN TRAM


Information gathered on 12/31/2009. No claim is made regarding the current trademark status. This page is not to be used as legal documentation. Always consult a licensed attorney.

Based on public records. Inadvertent errors are possible.
This web site is not associated with, endorsed by, or sponsored by and has no official or unofficial affiliation with the trademark's owners.